Exelixis (EXEL)
Create an Alert
4.82
+0.15 +3.21%
NASDAQ
Jun 18, 8:00PM
BATS Real time
Currency in USD
Exelixis Net Income Quarterly:
-44.73M for March 31, 2013Exelixis Historical Net Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -44.73M |
| Dec. 31, 2012 | -52.19M |
| Sept. 30, 2012 | -32.81M |
| June 30, 2012 | -36.49M |
| March 31, 2012 | -26.15M |
| Dec. 31, 2011 | 46.30M |
| Sept. 30, 2011 | 77.86M |
| June 30, 2011 | -20.98M |
| March 31, 2011 | -27.49M |
| Dec. 31, 2010 | -17.86M |
| Sept. 30, 2010 | -8.603M |
| June 30, 2010 | -22.61M |
| March 31, 2010 | -43.25M |
| Dec. 31, 2009 | -28.83M |
| Sept. 30, 2009 | -25.44M |
| June 30, 2009 | -44.76M |
| March 31, 2009 | -36.18M |
| Dec. 31, 2008 | -37.95M |
| Sept. 30, 2008 | -38.51M |
| June 30, 2008 | -45.12M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Net Income
Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.
Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More
EXEL Net Income Quarterly Benchmarks
| Companies | |
|---|---|
| Ariad Pharmaceuticals | -64.67M |
| Dendreon | -72.00M |
| ACADIA Pharmaceuticals | -6.123M |
EXEL Net Income Quarterly Rankings
| Overall |
42nd percentile 9577 of 16773 |
| Sector |
29th percentile 997 of 1408 in Healthcare |
| Industry |
24th percentile 341 of 453 in Biotechnology |
EXEL Net Income Quarterly Range, Past 5 Years
| Minimum | -52.19M | Dec 2012 |
| Maximum | 77.86M | Sep 2011 |
| Average | -23.29M |
